[Gilead Sciences](https://www.gilead.com)

June 2026 (annual application deadline, projected)

Funding levels not specified; details provided via initiative page or by inquiry.

Supports hepatitis C screening, harm reduction, and healthcare infrastructure projects in five Appalachian states affected by the opioid crisis.

Eligibility and funding details may vary; check the initiative page for the latest requirements.

--- ## Description HepConnect is a strategic initiative by Gilead Sciences designed to address the hepatitis C epidemic in five Appalachian states significantly impacted by the opioid crisis. The program aims to expand hepatitis C screening, support harm reduction services such as syringe programs and overdose prevention education, and strengthen healthcare infrastructure to better identify, treat, and support people living with or at risk for hepatitis C. The initiative partners with local organizations and health systems to drive sustainable improvements in public health and capacity building in affected communities. --- ## Due Dates - June 2026 (anticipated/projected annual application deadline) *All dates are projected based on the annual cycle; check the program page for updates.* --- ## Funding Amount - Specific per-grant funding levels or caps are not publicly specified. - Funding details are typically provided through the HepConnect initiative page or upon inquiry. - Awards may cover project costs for screening, harm reduction, or infrastructure expansion. --- ## Eligibility - Organizations must operate in one of the five Appalachian states targeted by the initiative (refer to the program page for the exact list). - Eligible applicants include: - Community-based organizations - Healthcare providers - Public health entities - Other groups working in viral hepatitis, harm reduction, or addiction-related services - Projects should address hepatitis C, harm reduction, or health systems capacity in communities affected by the opioid crisis. --- ## Application Process - Full program information, eligibility details, and application instructions are provided on the [HepConnect initiative page](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/hepconnect). - Applicants may be required to submit a proposal outlining their project scope, impact, and alignment with HepConnect’s objectives. - For broader partnership opportunities, applicants can use the [Partnership Request form](https://www.gilead.com/contact-us/partnership-request). --- ## Additional Information - Eligibility criteria, funding details, and application requirements may be updated annually. - Applicants are encouraged to review the initiative’s official page for the most current information and geographic eligibility. - The initiative prioritizes projects that directly address hepatitis C screening, harm reduction, and capacity building in the context of the opioid crisis. --- ## External Links - [HepConnect Initiative Page](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/hepconnect) - [Gilead Strategic Initiatives Overview](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives) - [Partnership Request Form](https://www.gilead.com/contact-us/partnership-request) --- ## Contact Information | Type | Details | |-----------------------|------------------------------------------------------------| | General Inquiries | [grants@gilead.com](mailto:grants@gilead.com) | | Phone | +1 (650) 574 3000 | | Program Information | [HepConnect Initiative Page](https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/strategic-initiatives/hepconnect) | | General Contact Form | [Contact Gilead](https://www.gilead.com/contact-us) |

HepConnect

Sign in to see full grant listing